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Introduction
The emergence of a pathogenic state known as denture
stomatitis, which is associated with biofilm formation by
Candida species, particularly Candida albicans and Can-
dida glabrata (Coco et al. 2008), is common in complete
denture wearers. Candida infections display increased
resistance to antifungal therapy, leading to treatment
failure and to recalcitrant infections (Watamoto et al.
2009). This fact has stimulated the possibility of using
silver nanoparticles (SN) to control Candida biofilm
formation.
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Abstract
Aim: The purpose of this work was to evaluate the size-dependent antifungal
activity of different silver nanoparticles (SN) colloidal suspensions against
Candida albicans and Candida glabrata mature biofilms.
Methods and Results: The research presented herein used SN of three different
average sizes (5, 10 and 60 nm), which were synthesized by the reduction of
silver nitrate through sodium citrate and which were stabilized with ammonia
or polyvinylpyrrolidone. Minimal inhibitory concentration (MIC) assays were
performed using the microdilution methodology. The antibiofilm activity of
SN was determined by total biomass quantification (by crystal violet staining)
and colony forming units enumeration. MIC results showed that all SN colloi-
dal suspensions were fungicidal against the tested strains at very low concentra-
tions (0Æ4–3Æ3 lg ml)1). With regard to biomass quantification, SN colloidal
suspensions were very effective only against C. glabrata biofilms, achieving
biomass reductions around 90% at a silver concentration of 108 lg ml)1. In
general, all SN suspensions promoted significant log10 reduction of the mean
number of cultivable biofilm cells after exposure to silver concentrations at or
higher than 108 lg ml)1. Moreover, the results showed that the particle size
and the type of stabilizing agent used did not interfere in the antifungal activity
of SN against Candida biofilms.
Conclusions: This study suggests that SN have antifungal therapeutic potential,
but further studies are still required namely regarding formulation and delivery
means.
Significance and Impact of the Study: SN may contribute to the development
of new strategies for the improvement of oral health and quality of life particu-
larly of the complete denture wearers.
Letters in Applied Microbiology ISSN 0266-8254
ª 2012 The Authors
Letters in Applied Microbiology 54, 383–391 ª 2012 The Society for Applied Microbiology 383
The chemical reaction method is one of the most
employed and inexpensive methods to synthesize SN. It is
based on the use of a reducing agent (e.g., sodium citrate)
to reduce Ag+ to Ag0 and a stabilizer [e.g., ammonia
(NH3), polyvinylpyrrolidone (PVP)] to control particle
growth and prevent aggregation (Kvı´tek et al. 2008;
Gorup et al. 2011; Monteiro et al. 2012). The SN action
mechanism against bacterial and fungal cells is relatively
well described (Monteiro et al. 2009), and as, according
to Allaker (2010), silver may act on a broad range of
microbial targets, many mutations need to occur for
micro-organisms to resist its antimicrobial effect. More-
over, an inverse relationship between SN size and antimi-
crobial activity has been demonstrated by Baker et al.
(2005), who reported that smaller particles, with a larger
surface area available for interaction with planktonic
microbial cells, were more effective than larger particles.
Although the activity of SN against C. albicans and
C. glabrata adhered cells and biofilms was demonstrated
recently (Monteiro et al. 2011), research regarding the sus-
ceptibility of Candida biofilms to SN of different sizes, and
synthesized with different stabilizing agents, is unknown at
the moment. For this reason, the current study investi-
gated, through the quantification of total biomass and cul-
tivable cells, the size-dependent antifungal activity against
C. albicans and C. glabrata biofilms of SN synthesized with
two different stabilizing agents. The null hypotheses were
that: (i) there would be no difference among the different
sizes of SN in decreasing total biomass and cultivable cells
of Candida biofilms, and (ii) the type of stabilizing agent
would not interfere with SN efficacy.
Materials and methods
Synthesis and characterization of silver colloidal
nanoparticles
For the synthesis of silver colloidal nanoparticles, silver
nitrate (AgNO3), sodium citrate (Na3C6H5O7) and ammo-
nia (NH3) were provided by Merck KGaA (Darmstadt;
Germany) and PVP was obtained from Sigma-Aldrich, (St
Louis, MO). SN of three different sizes: 5 (SN5), 10
(SN10) and 60 (SN60) nm, and stabilized with NH3 (N)
or PVP (P), were prepared according to the procedure
reported by Gorup et al. (2011). Briefly, 7Æ5 ml of a solu-
tion of sodium citrate at 0Æ3 mol l)1 and five drops of
ammonia (1Æ4 mol l)1) were added to a tri-neck flask con-
taining 150 ml of an aqueous solution of AgNO3 at 5Æ0 ·
10)3 mol l)1 under the temperature of 90C. The solution
was kept stirring at 90C until it turned yellow, indicating
the formation of SN. The silver colloidal nanoparticles
were stabilized by adding 7Æ5 ml of a solution with
1Æ4 mol l)1 of NH3. The new solution was kept stirring
and heating for two more minutes, and the suspension
was then allowed to cool at room temperature. In another
flask, 1 ml of a solution of 102 g l)1 of PVP was added to
the colloidal silver after lowering of the temperature. To
characterize the silver colloidal nanoparticles suspensions,
UV ⁄Visible absorption spectroscopy (Spectrophotometer
Shimadzu MultSpec-1501; Shimadzu Corporation, Tokyo,
Japan) and Transmission Electron Microscopy (TEM,
Electron Microscope FEG-VP Supra 35; Carl Zeiss, Jena,
Thu¨ringen, Germany) were performed.
Yeast strains and growth conditions
The nutrient source for biofilm formation was artificial
saliva, used to mimic the in vivo oral cavity conditions. It
was prepared according to Lamfon et al. (2003) and its
composition per 1 l of deionized water was: 2 g of yeast
extract (Liofilchem, Roseto degli Abruzzi, Italy), 5 g of
peptone (Liofilchem), 2 g of glucose (AppliChem, Darm-
stadt, Germany), 1 g of mucin (Sigma-Aldrich), 0Æ35 g of
NaCl (AppliChem), 0Æ2 g of CaCl2 (Riedel-de Hae¨n,
Seelze, Germany) and 0Æ2 g of KCl (Pronalab, Lisbon,
Portugal). The pH was adjusted with NaOH (Pronalab)
to 6Æ8.
Candida strains used for the present experiments were
C. albicans 324LA ⁄ 94 (provided by the culture collection
of Cardiff Dental School, Cardiff, UK) and C. glabrata D1
(obtained from the biofilm group of the Centre of Biolog-
ical Engineering, University of Minho, Braga, Portugal),
both being oral clinical isolates. Yeasts were first subcul-
tured on Sabouraud dextrose agar medium (SDA; Liofil-
chem) at 37C for 24 h. A cellular suspension of each
yeast strain was prepared in Sabouraud dextrose broth
(SDB; Liofilchem) medium and incubated overnight at
37C and 120 rev min)1. Afterwards, the cells were har-
vested by centrifugation (6500 g for 5 min at 15C),
washed twice in phosphate-buffered saline (PBS; pH 7)
and adjusted to a concentration of 107 cells per ml in
artificial saliva, using a Neubauer counting chamber.
Determination of minimum inhibitory concentrations
(MICs)
MICs were determined for the six colloidal suspensions of
SN against both Candida strains in accordance with the
guidelines of the Clinical Laboratory Standards Institute
(CLSI) (M27-A2), as detailed in a previous study (Monte-
iro et al. 2011).
Biofilm formation and treatment with SN
Mature Candida biofilms aged 48 h were formed in
96-well microtiter plates according to Silva et al. (2010).
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Briefly, 200 ll of Candida cell suspension (1 · 107 cells
per ml in artificial saliva) was placed into each well and
incubated at 37C under 120 rev min)1. Artificial saliva
medium was renewed after 24 h. Following Candida bio-
film formation (48 h), the medium was aspirated and
nonadherent cells were removed by washing with 200 ll
of PBS. Next, RPMI 1640 medium (200 ll) containing
different concentrations (0Æ4, 1Æ6, 6Æ7, 13Æ5, 27, 54, 108
and 216 lg ml)1) of each SN suspension was then added
to the preformed biofilms. The microtiter plates were
incubated at 37C for 24 h in an orbital shaker incubator
at 120 rev min)1. After treatment with SN, biofilms were
washed once with PBS to remove loosely attached cells.
Controls devoid of silver were included in the assay. All
assays were performed independently three times in tripli-
cate.
Biofilm quantification
Biomass of Candida biofilms treated with SN was evalu-
ated by the crystal violet (CV) staining method. Initially,
200 ll of 99% methanol (Romil, Cambridge, UK) was
added to the biofilms for 15 min to allow cell fixation.
After, methanol was removed and the microtiter plates
were dried at room temperature. Then, 200 ll of CV
stain (1% v ⁄ v) (Merck) was added into the wells contain-
ing biofilms previously fixed. After 5 min, the excess of
CV was removed and the plates were washed with deion-
ized water and allowed to dry at room temperature.
Afterwards, 200 ll of acetic acid (33% v ⁄ v) (Pronalab)
was pipetted into each well to dissolve and remove the
CV stain from the biofilms. Finally, absorbance was mea-
sured at 570 nm. The assays were performed in triplicate
and on three separate occasions.
For cultivable counts of Candida biofilm cells exposed
to SN, biofilms were scraped from the wells and the sus-
pensions obtained were vigorously vortexed for 5 min to
disaggregate cells. Serial dilutions (in PBS) of each biofilm
cell suspension were prepared and plated on SDA, and
the plates were incubated at 37C. After 24 h, the total
number of colony forming units (CFUs) per unit area
(log10 CFU cm
)2) of microtiter plate well was enumer-
ated. For each condition studied, three separate experi-
ments were performed.
Statistical analysis
Biofilm biomass and cultivable cells of the treated groups
with SN were analysed using analysis of variance (anova)
followed by Bonferroni test. Statistical analyses were per-
formed with the spss software (SPSS – Statistical Package
for the Social Sciences, Inc., Chicago, IL, USA) with sig-
nificance of 5%.
Results
Silver colloidal nanoparticles characterization
SN at 540 lg ml)1 with different diameters were formed
through the reduction of AgNO3 with Na3C6H5O7 fol-
lowed by stabilization with NH3 (N) or PVP (P). These
procedures led to six different colloidal suspensions of
SN, depending on the stabilizing agent used and the
particle size: SN5-N, SN5-P, SN10-N, SN10-P, SN60-N
and SN60-P. In the UV ⁄Visible analysis (Fig. 1), the
absorption peak of SN ranged from 430 to 460 nm,
characterizing the nanosized silver particles. The absorp-
tion spectra of the SN5-N, SN5-P, SN10-N and SN10-P
colloidal suspensions (Fig. 1aI,aII,bI,bII) demonstrated
well-defined plasmon bands centred at 430 nm. In the
case of SN60-N and SN60-P (Fig. 1cI,cII), the absorp-
tion peaks were attained at approximately 460 nm, pos-
sibly because of the larger size of the particles. The
symmetrical shapes of all plasmon bands in Fig. 1 con-
firmed the colloidal stability and sharp particle size dis-
tribution. These bands have been commonly assigned to
nanoparticles having a spherical or spheroidal shape.
TEM observations (Fig. 2) indicated that the nanoparti-
cles were well formed, nearly spherical and dispersed,
and with mean diameters of 5 (Fig. 2aI,aII), 10 (Fig. 2-
bI,bII) and 60 nm (Fig. 2cI,cII). Furthermore, it can be
noted a few agglomerates of particles mainly when stabi-
lized by PVP (Fig. 2bII,cII).
Minimum inhibitory concentration
MICs of the six SN colloidal suspensions determined
against planktonic cells of Candida are shown in Table 1.
It was possible to observe that the two species of Candida
were susceptible to all the SN tested in very low concen-
trations. The lowest MIC values were against C. albicans
324LA ⁄ 94, using SN5-N, SN60-N and SN60-P (0Æ4–
0Æ8 lg ml)1). Additionally, between the two Candida spp.
tested, C. glabrata D1 was the least susceptible to SN,
with MIC values ranging from 0Æ8 to 3Æ3 lg ml)1. With
regard to the particle size and the stabilizing agents, inter-
estingly, MIC values for each Candida species remained
almost the same. Solutions of Na3C6H5O7, NH3 and PVP,
used as controls, did not exhibit any antifungal activity
on the Candida spp. assayed.
Biofilm quantification
The results displayed in Fig. 3a show that SN were not
effective in reducing total biomass of C. albicans
324LA ⁄ 94 biofilms. Interestingly, it was possible to note
that, at concentrations ranging from 0Æ4 to 108 lg ml)1,
D.R. Monteiro et al. Silver against Candida biofilms
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all SN colloidal suspensions promoted an increase in bio-
film biomass regardless of the silver concentration tested,
except for SN5-N. When compared to the control values,
the biomass increase was significant for SN10-N at con-
centrations of 1Æ6 (P = 0.001), 6Æ7 (P = 0.003), 13Æ5
(P = 0.004), 27 (P = 0.019) and 216 lg ml)1 (P = 0.002),
and for SN60-N at a concentration of 216 lg ml)1
(P = 0.032). Curiously, the comparisons of different col-
loidal suspensions at the same silver concentration
showed no statistical differences (P > 0.05).
However, on C. glabrata D1 (Fig. 3b), all SN colloidal
suspensions were very effective in reducing total biomass
after 24 h of treatment of mature biofilms (formed for
48 h). When compared to the control groups (biofilms
without SN) SN5-N, SN5-P, SN10-N, SN10-P, SN60-N
and SN60-P showed significant biomass reduction at silver
concentrations greater than or equal to 1Æ6 (P = 0.001),
6Æ7 (P = 0.011), 13Æ5 (P = 0.002), 6Æ7 (P = 0.001), 1Æ6
(P = 0.011) and 6Æ7 lg ml)1 (P < 0.001), respectively. In
general, C. glabrata D1 demonstrated a biofilm biomass
reduction dependent on silver concentration, achieving
biomass reductions greater than 50% at a concentration
of 13Æ5 lg ml)1 and around 90% at a concentration of
108 lg ml)1, for all colloidal suspensions tested.
Regarding the effect of SN on biofilm cultivable cells,
Fig. 4 presents mean values and standard deviations of
log10 CFU cm
)2 for both Candida species. For C. albicans
324LA ⁄ 94 (Fig. 4a), after 24 h of biofilms treatment with
SN colloidal suspensions, it was noted that the smaller par-
ticles (SN5-N and SN5-P) had the antifungal activity signif-
icantly increased from a concentration of 27 (P = 0.006)
and 13Æ5 lg ml)1 (P < 0.015), respectively. In addition,
using SN5-N and SN5-P at a silver concentration of
216 lg ml)1, there was 3Æ51-log10 (P < 0.001) and 3Æ36-
log10 (P < 0.001) reduction in the number of CFUs, respec-
tively, compared to the control groups. However, SN10-N
similarly to SN10-P, and SN60-N similarly to SN60-P,
started significant decrease in the number of CFUs in con-
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Figure 1 UV-visible spectra of silver nanopar-
ticles (SN) colloidal suspensions with 5 (a), 10
(b) and 60 nm (c), stabilized with ammonia (I)
and polyvinylpyrrolidone (II).
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centrations over 54 (P = 0.002; P = 0.007) and 27 lg ml)1
(P = 0.027; P = 0.015), respectively, suggesting the type of
stabilizing agent was not decisive for antifungal activity
against C. albicans 324LA ⁄ 94 biofilms. Comparing the dif-
ferent SN colloidal suspensions within the same silver con-
centration, no significant statistical differences (P > 0.05)
were found in the average number of log10 CFUs.
For C. glabrata D1 (Fig. 4b), when each SN colloidal
suspension was evaluated separately and compared to the
control groups, the data showed that the SN5-N
(P = 0.015) and SN10-P (P < 0.010) colloidal suspensions
induced a significant decrease in the number of biofilm
cells at silver concentrations above 54 lg ml)1 while for
SN5-P (P < 0.001), SN10-N (P = 0.006), SN60-N
(P = 0.010) and SN60-P (P = 0.009) this activity was sta-
tistically significant for silver concentrations greater than
or equal to 27 lg ml)1. SN5-P and SN60-P at silver con-
centration of 216 lg ml)1 exhibited the highest reduc-
tions in the average number of CFUs, with reductions of
4Æ24-log10 (P < 0.001) and 3Æ72-log10 (P < 0.001), respec-
tively, when compared to the control groups. On the
other hand, comparisons of the different SN colloidal sus-
pensions within the same silver concentration did not
indicate significant differences (P > 0.05). Thus, in gen-
eral, according to the biofilm quantification results
obtained in this study, the particle size and the type of
SN stabilizing agent did not affect the antifungal activity
of SN against Candida biofilms.
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Figure 2 Transmission electron microscopy
images of silver nanoparticles (SN) with 5 (a),
10 (b) and 60 nm (c), stabilized with ammonia
(I) and polyvinylpyrrolidone (II).
Table 1 Minimum inhibitory concentrations (MICs) of silver nanoparticles (SN) stabilized with ammonia (NH3) and polyvinylpyrrolidone (PVP)
against Candida spp.
Candida spp.
MIC (lg ml)1)
SN stabilized with NH3 SN stabilized with PVP
5 nm 10 nm 60 nm 5 nm 10 nm 60 nm
Candida albicans 324LA ⁄ 94 0Æ4–0Æ8 0Æ8 0Æ4 0Æ8 0Æ8–1Æ6 0Æ4–0Æ8
Candida glabrata D1 1Æ6–3Æ3 1Æ6 0Æ8–1Æ6 1Æ6–3Æ3 3Æ3 1Æ6–3Æ3
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Discussion
Denture stomatitis is a pathogenic state common in
complete denture wearers, and its infective causes
include some micro-organisms, mainly C. albicans and
C. glabrata (Coco et al. 2008). Therefore, the ability of
SN to inhibit Candida biofilms was evaluated against the
aforesaid micro-organisms. The results of the present
study did not allow the rejection of the null hypotheses,
which are that the nanoparticle size and the type of sta-
bilizing agent would not interfere with SN efficacy in
decreasing total biomass and cultivable cells of Candida
biofilms.
Because SN may not only act in the biofilm cells, but
also in their matrix, CV staining assay was performed to
quantify the total biomass of Candida biofilms. This assay
does not allow differentiation between living and dead
cells, so it cannot be used for susceptibility testing of bio-
films. CV staining was used as a complement to CFU
enumeration. From Fig. 3, it is possible to observe that
the different SN were very effective against C. glabrata
D1 biofilms, with significant biomass reduction at silver
concentrations greater than or equal to 1Æ6 lg ml)1 for all
conditions (diameter and solution) assayed. For this
species, all SN colloidal suspensions showed biomass
reductions around 90% at a silver concentration of
108 lg ml)1. However, in general, for C. albicans 324LA ⁄94
biofilms, there was some increase in biofilm biomass
when compared to untreated biofilms, including different
particle sizes and solutions. These differences in the effect
of SN on both species could be due to their biofilm
architectures, which present several dissimilarities. Can-
dida glabrata biofilms are exclusively composed of blas-
tospores and devoid of hyphal cells, while C. albicans is a
polymorphic organism, able to grow as hyphae, pseudo-
hyphae and blastospores (Silva et al. 2011). Accordingly,
C. albicans biofilms are more complex and difficult to
eradicate. Furthermore, the biofilm formation and matrix
production processes are dependent upon species, strains
and environmental conditions (Silva et al. 2011). When
biofilms are exposed to stress conditions, physiological
changes can occur to protect the cells (Mah and O’Toole
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Figure 3 Absorbance values per cm2 obtained with crystal violet staining assay for Candida albicans 324LA ⁄ 94 (a) and Candida glabrata D1 (b)
mature biofilms after 24 h of treatment with silver nanoparticles (SN) with 5 (SN5), 10 (SN10) and 60 nm (SN60), which were stabilized using
ammonia (N) and plyvinylpyrrolidone (P). Error bars indicate the standard deviations of the means. *P < 0Æ05, as compared to the control groups
by using a one-way anova followed by Bonferroni test. (a) Silver concentration (lg ml)1): ( ) 0; ( ) 0Æ4; ( ) 1Æ6; ( ) 6Æ7; ( ) 13Æ5; ( ) 27; ( )
54; ( ) 108 and (h) 216. (b) Silver concentration (lg ml)1): ( ) 0; ( ) 0Æ4; ( ) 1Æ6; ( ) 6Æ7; ( ) 13Æ5; ( ) 27; ( ) 54; ( ) 108 and (h) 216.
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2001). This may suggest an increased production of exo-
polymeric substances by C. albicans 324LA ⁄ 94 biofilms in
the presence of SN, which could explain the increase in
total biomass observed in Fig. 3a, accompanied by a slight
decrease in the number of viable biofilm cells.
Moreover, the silver concentrations above which signif-
icant reductions were detected in the number of biofilm
cells of C. albicans 324LA ⁄ 94 (Fig. 4a) and C. glabrata D1
(Fig. 4b), were about 17–135 and 16Æ5 to 34-fold higher,
respectively, than the corresponding MICs (Table 1), con-
firming the lower susceptibility of biofilm cells. These
MIC results revealed that all SN colloidal suspensions
presented similar behaviours, all being fungicidal (in con-
centrations ranging from 0Æ4 to 3Æ3 lg ml)1) against the
two Candida isolates when in the planktonic growth
mode (Table 1). Additionally, these fungicidal activities
were confirmed by plating the content of each well on
SDA. The data obtained are in agreement with the previ-
ously published results by Hawser and Douglas (1995).
These authors found that all of the antifungal agents
tested (amphotericin B, flucytosine, fluconazole, itraco-
nazole and ketoconazole) showed much less activity
against 48-h C. albicans biofilms than against planktonic
cells. The drug concentrations that caused 50% inhibition
in biofilms were 30–2000 times higher than the relevant
MICs (Hawser and Douglas 1995). In fact, C. albicans
and C. glabrata form recalcitrant biofilms which are dif-
ficult to eradicate (Lewis 2001), because of increasing tol-
erance to conventional antifungal therapy (Silva et al.
2012). According to Silva et al. (2012), the mechanisms
of biofilm drug resistance ⁄ tolerance are not fully under-
stood, but can be considered a multifactorial phenome-
non. In combination or alone, these mechanisms include
decreased growth rate (Lewis 2001), heterogeneity, expres-
sion of resistance genes and presence of ‘persister’ cells
within the biofilm (Lewis 2001; Mah and O’Toole 2001).
In addition, although some SN may diffuse inside the
matrix through the water channels present in the biofilm
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Figure 4 Logarithm of colony forming units per cm2 obtained for Candida albicans 324LA ⁄ 94 (a) and Candida glabrata D1 (b) mature biofilms
after 24 h of treatment with silver nanoparticles (SN) with 5 (SN5), 10 (SN10) and 60 nm (SN60), which were stabilized using ammonia (N) and
plyvinylpyrrolidone (P). Error bars indicate the standard deviations of the means. *P < 0Æ05, when each SN colloidal suspension was evaluated sep-
arately and compared to the control groups by using a one-way anova followed by Bonferroni test. (a) Silver concentration (lg ml)1): ( ) 0; ( )
0Æ4; ( ) 1Æ6; ( ) 6Æ7; ( ) 13Æ5; ( ) 27; ( ) 54; ( ) 108 and (h) 216. (b) Silver concentration (lg ml)1): ( ) 0; ( ) 0Æ4; ( ) 1Æ6; ( ) 6Æ7; ( ) 13Æ5;
( ) 27; ( ) 54; ( ) 108 and (h) 216.
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architecture, the micro-organisms present on the deeper
layers may escape the treatment as the matrix hampers
the drug diffusion (Kalishwaralal et al. 2010).
Regarding cell viability (Fig. 4), although all SN pre-
sented a similar behaviour, they were more effective on
C. glabrata D1 than against C. albicans 324LA ⁄ 94 bio-
films. However, for both species in general, a significant
reduction in the number of biofilm viable cells for silver
concentrations at or higher than 13Æ5 lg ml)1 was
observed. Interestingly, the highest silver concentration
(216 lg ml)1) did not have a significantly greater antibio-
film effect than the lowest concentrations (54 and
108 lg ml)1), characterizing a relatively weak dose–
response, except for SN5-P against C. glabrata D1, high-
lighting the similarities between the particles. Accordingly,
these findings also suggest that it may not be necessary to
use the highest silver concentrations.
SN colloidal suspensions were prepared with NH3 and
PVP as stabilizers. NH3 stabilizes metallic SN by the for-
mation of soluble diammine silver (I) complexes,
which trap free silver ions responsible for particle growth
(Gorup et al. 2011). The polymers of the PVP group
bond on the SN surfaces through the nitrogen atom in
their molecule (Kvı´tek et al. 2008), resulting in floccula-
tion. Kvı´tek et al. (2008) reported that despite the floccu-
lation process, the SN stabilized by PVP are separated
from each other through the chain of the polymer mole-
cule, and these SN can interact with the cell wall of a
micro-organism because of their high surface energy and
mobility. Furthermore, according to the literature (Baker
et al. 2005), smaller SN are more effective than larger par-
ticles, because of a larger surface area available for inter-
action with cells. However, as referred, CV staining and
CFU analysis (Figs 3 and 4) showed that the particle size
range assayed and the type of stabilizing agent did not
interfere with the antifungal activity of SN against Can-
dida biofilms. Choi et al. (2010) demonstrated, through
laser-scanning confocal microscopic observations, that the
interactions of SN with Escherichia coli biofilm cells
resulted in particle aggregation with a final average aggre-
gate size of about 800 nm (an increase by a factor of 40).
Moreover, Stewart and Franklin (2008) reported that bio-
film features, such as oxygen availability, substrate, pH
range and extracellular polymeric substances composition,
may influence aggregation, dissolution and diffusive
transport of SN. Taken together, all these observations
reinforce the idea that SN aggregation may have occurred
and, consequently, causing an increase in particle size.
Probably due to this fact, it was not possible to observe
any significant difference among SN colloidal suspensions
and an inverse relationship between SN size and
antifungal activity.
Furthermore, it would be reasonable to hypothesize
that the aggregation of SN within the biofilms led to a
particle size which conflicted extensively from that origi-
nally synthesized. This fact disallowed discriminating the
effect of particle size and stabilizing agent on Candida
biofilms. These observations emphasize that the original
particle size may be a poor display of true nanoparticle
size in biofilms and therefore also of antifungal activity.
In other words, the results of the present study imply that
biofilms are influencing by the aggregation of SN and that
the size of nanoparticles and the type of stabilizing agent
were not crucial to their positive effect on Candida bio-
films. Possibly, only the well dispersed SN may act against
Candida biofilms effectively.
In summary, the particle size and the type of stabilizing
agent do not interfere with the in vitro antimicrobial effi-
cacy of SN. On the basis of these findings, additional
investigations with silver colloidal nanoparticles will be
needed regarding their therapeutic potential, namely to
assess formulation and delivery means.
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